Category & Conditions: Cancer
Study Phase : 3
Medicine: BAVENCIO(AVELUMAB)
PrintDownloadCategory & Conditions: Cancer
Study Phase : 1/2
Medicine: DAURISMO TABLETS(GLASDEGIB)
PrintDownloadCategory & Conditions: Cancer
Study Phase : 3
Medicine: IBRANCE®(PALBOCICLIB)
PrintDownloadCategory & Conditions: Cancer
Study Phase : 1
Medicine: INLYTA®(AXITINIB)
PrintDownloadCategory & Conditions: Neurological Diseases and Conditions
Study Phase : 3
Medicine: LYRICA® AND LYRICA®CR(PREGABALIN) AND (PREGABALIN EXTENDED RELEASE TABLETS)
PrintDownloadCategory & Conditions: Neurological Diseases and Conditions
Study Phase : 3
Medicine: LYRICA® AND LYRICA®CR(PREGABALIN) AND (PREGABALIN EXTENDED RELEASE TABLETS)
PrintDownloadCategory & Conditions: Cardiovasular Diseases and Conditions
Study Phase : 3
Medicine: REVATIO®(SILDENAFIL)
PrintDownloadCategory & Conditions: Cancer
Study Phase : 1
Medicine: VIZIMPRO® TABLETS(DACOMITINIB)
PrintDownloadCategory & Conditions: Cancer
Study Phase : 2
Medicine: VIZIMPRO® TABLETS(DACOMITINIB)
PrintDownloadCategory & Conditions: Cardiovasular Diseases and Conditions
Study Phase : 3
Medicine: VYNDAQEL® (TAFAMIDIS MEGLUMINE) CAPSULES AND VYNDAMAX™ (TAFAMIDIS) CAPSULES
PrintDownloadCategory & Conditions: Immune System Diseases and Conditions
Study Phase : 3
Medicine: XELJANZ®(TOFACITINIB)
PrintDownloadCategory & Conditions: Skin Diseases and Conditions
Study Phase : 3
Medicine: abrocitinib (PF-04965842)
PrintDownloadCategory & Conditions: Skin Diseases and Conditions
Study Phase : 3
Medicine: abrocitinib (PF-04965842)
PrintDownloadCategory & Conditions: Cancer
Study Phase : 3
Medicine: Bavencio (avelumab)
PrintDownloadCategory & Conditions: Cancer
Study Phase : 3
Medicine: Bavencio (avelumab), PF-05082566
PrintDownloadCategory & Conditions: Rare Diseases
Study Phase : 2
Medicine: fidanacogene elaparvovec (PF-06838435)
PrintDownloadCategory & Conditions: Vaccine-related Conditions
Study Phase : 3
Medicine: PF-06482077
PrintDownloadCategory & Conditions: Vaccine-related Conditions
Study Phase : 3
Medicine: PF-06482077
PrintDownloadCategory & Conditions: Cancer
Study Phase : 1
Medicine: PF-06647020
PrintDownloadCategory & Conditions: Vaccine-related Conditions
Study Phase : 2
Medicine: PF-06928316
PrintDownload